Other morbid association(s)
|
Type | Gene Modification | Chromosome rearrangement | Protein expression | Protein Function
|
---|
tumoral
|  
| translocation
|  
|  
|
acquired translocation t(12;15)(p13;q25) in congenital mesoblastic nephroma (CMN), and in tumour development | tumoral
| fusion
| translocation
|  
| protein chimeric
|
acquired t(12;15)(p13;q25) leading to a ETV6-NTRK3 gene fusion in congenital or infantile fibrosarcoma, in pediatric spindle cell sarcomas and secretory breast carcinoma | tumoral
| somatic mutation
|  
|  
|  
|
in breast, lung, and pancreatic cancers | tumoral
|  
|  
| --over
|  
|
in medulloblastomas, identified as a powerful independent predictor of favorable survival outcome | tumoral
|  
|  
| --over
|  
|
in disfiguring cutaneous appendageal tumours of CYLD | tumoral
|  
|  
| --low
|  
|
in a large fraction of human colorectal cancers, mainly through promoter methylation | tumoral
| fusion
|  
|  
|  
|
fusion gene PLEKHA6-NTRK3 in langerhans cell histiocytosis | |